Hutchinson Capital Management’s AbbVie ABBV Stock Holding History

Hutchinson Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Buy	+842	New	+$181K	0.04%	104
2025 Q4	–	Sell	-914	Closed	-$212K	–	99
2025 Q3	$212K	Buy	+914	New	+$186K	0.04%	91
2024 Q3	–	Sell	-1,317	Closed	-$226K	–	90
2024 Q2	$226K	Sell	1,317 -28	-2%	-$4.64K	0.05%	83
2024 Q1	$245K	Buy	1,345 +20	+2%	+$3.45K	0.05%	75
2023 Q4	$205K	Sell	1,325 -29	-2%	-$4.23K	0.04%	82
2023 Q3	$202K	Buy	+1,354	New	+$199K	0.05%	79
2023 Q2	–	Sell	-1,257	Closed	-$200K	–	78
2023 Q1	$200K	Buy	1,257 +2	+0.2%	+$306	0.05%	69
2022 Q4	$203K	Buy	+1,255	New	+$192K	0.05%	67
2022 Q1	–	Sell	-1,486	Closed	-$201K	–	72
2021 Q4	$201K	Buy	+1,486	New	+$176K	0.04%	72
2014 Q3	–	Sell	-6,105	Closed	-$345K	–	60
2014 Q2	$345K	Sell	6,105 -50	-0.8%	-$2.62K	0.1%	48
2014 Q1	$316K	Hold	6,155	–	–	0.09%	46
2013 Q4	$325K	Sell	6,155 -134	-2%	-$6.59K	0.09%	48
2013 Q3	$281K	Buy	6,289 +373	+6%	+$16.5K	0.09%	50
2013 Q2	$245K	Buy	+5,916	New	+$259K	0.08%	52

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hutchinson Capital Management's ABBV Position: Q2 2026 in Review

Hutchinson Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 842 shares worth $212K. The stake represents 0.04% of the portfolio and ranks #104 among its holdings. This is a return to the name: Hutchinson Capital Management previously reported a position in ABBV as recently as Q3 2025.

Hutchinson Capital Management first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $345K in Q2 2014. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Hutchinson Capital Management held 842 shares of AbbVie worth $212K as of Q2 2026.
AbbVie was a new Hutchinson Capital Management position in Q2 2026.
AbbVie made up 0.04% of Hutchinson Capital Management's portfolio in Q2 2026, its #104 holding.
Hutchinson Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
Hutchinson Capital Management's AbbVie position peaked at $345K in Q2 2014.
4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hutchinson Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.